Provided herein are compositions for skin care comprising cannabidiol, probiotics, and microalgae, optionally in a particular weight ratio. Optionally the compositions further comprise one or more of an antioxidant, a cleansing agent, an alcohol, an oil, and/or a flower or seed extract.

Stable cream gel dermatological/cosmetic compositions useful, e.g., for the treatment of acne vulgaris, contain, formulated into a physiologically acceptable medium, a homogeneous dispersion of at least one dispersed retinoid, dispersed benzoyl peroxide, at least one lipophilic compound and at least one gelling agent.

Disclosed is a method of treating a fine line or wrinkle in a person's skin, the method comprising topically applying to the fine line or wrinkle a composition comprising an effective amount of Commiphora mukul resin or an extract thereof that includes oleo gum resin, glycerin, water, and hyaluronic acid or a salt form thereof, wherein topical application of the composition to the fine line or wrinkle reduces the appearance of the fine line or wrinkle.

The present invention relates to the combination of a retinoid and an extract of Silybum marianum (L.) Gaertn., the dermatological and dermocosmetic compositions containing such a combination, as well as their uses as a medicinal product, in particular in the treatment of acne, seborrhea, seborrhoeic dermatitis and/or rosacea.

When a device mounted on a mask pack, and a mask pack and a kit including the device are used, the mask pack may be well attached onto an application site, for example, skin; delivery of a bioactive material via the skin may improve; and itching, pain, burning, and erythema that may occur during a process of delivering the bioactive material to the skin may be prevented by using the device including an electrode.

The present technology relates generally to devices for treatment of skin and skin conditions, as well as methods for preparing the devices and methods of treatment using the devices. Suitably, the devices comprise a hydrocolloid dressing and one or more active agents, wherein the amount of the active agent(s) does not reduce the absorption properties of the hydrocolloid dressing.

A composition for alleviating facial redness containing stem cell-derived exosomes as an active ingredient and a method of reducing facial redness are provided. When a facial skin is treated with the composition for alleviating facial redness containing stem cell-derived exosomes as an active ingredient, the composition exhibits an excellent effect on skin care by reducing the redness of the face and improving the appearance of the face.

A customizable platform for ingredient selectable skin treatments. End users purchase pre-configured kits, which provide pre-made combinations of active ingredients that are already grouped together. Next, end users configure their kits' active ingredients in the following ways: First an end user builds their own formulas with an active ingredients selection process, allowing the end user to specify the ingredients to include; Second, the end user completes a skin profile questionnaire where the end user answers a series of questions regarding their skin type and preferences. The platform analyzes user data to determine, create, and assemble the ideal skincare product for the end user. Skin care products are shipped in packaging that includes a base cream, active ingredients, and a spoon or other stirring device or apparatus for mixing. Upon receiving the kit, the end user mixes the cream together with the active ingredients to create a potent solution.

A method for managing a skin care system. The skin care system includes circuitry to receive skin information from a user. The circuitry determines treatable skin conditions based on the skin information. The skin care system generates severity information and cosmetic formulation compatibility information based on the treatable skin conditions. The skin care system is further able to virtually display user-specific compatible cosmetic formulations based on at least one parameter associated with the severity information and cosmetic formulation compatibility.

Disclosed are stable, non-irritating, skin treatment active agents containing formulations and delivery systems for topical application to the skin. The disclosed topical formulations and delivery systems provide controlled, gentle release of the active agents into the skin for the treatment of amenable skin conditions as well as for improvement of aesthetic skin properties. Also provided are methods for the formulation, manufacture and use of the disclosed formulations and delivery systems.